Lamivudine and Hepatitis B Reactivation

  1. Chiun Hsu, MD, PhD;
  2. Ann-Lii Cheng, MD, PhD; and
  3. Pei-Jer Chen, MD, PhD
  1. From National Taiwan University Hospital, Taipei, Taiwan.

    TO THE EDITOR:

    We read with great interest the systematic review by Loomba and colleagues (1) for chemotherapy-induced hepatitis B virus (HBV) reactivation in patients with cancer who tested positive for HBV surface antigen. However, some of the information quoted in the article needs clarification.

    In Table 1 of the article, regarding the use of corticosteroids as an important risk factor for chemotherapy-induced HBV reactivation (2), our study (3) and the study by Lau and colleagues …

    « Previous | Next Article »Table of Contents